Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study

BACKGROUND: Liver diseases are associated with the excess formation of advanced glycation end products (AGEs), which induce tissue inflammation and oxidative damage. However, the trend of oxidative marker levels according to the steatosis grade in non-alcoholic fatty liver disease (NAFLD) is unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Evelyn Nunes Goulart da Silva, Paula, Daniela Polessa, de Araujo, Beatriz Peres, da Fonseca, Maria de Jesus Mendes, Diniz, Maria de Fátima Haueisen Sander, Daliry, Anissa, Griep, Rosane Harter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371502/
https://www.ncbi.nlm.nih.gov/pubmed/34447235
http://dx.doi.org/10.3748/wjg.v27.i29.4913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371502/
https://www.ncbi.nlm.nih.gov/pubmed/34447235
http://dx.doi.org/10.3748/wjg.v27.i29.4913

Ejemplares similares